BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3713304)

  • 1. [Agranulocytosis caused by glucantime in the treatment of kala-azar].
    Gutiérrez Rodero F
    Med Clin (Barc); 1986 Mar; 86(10):437. PubMed ID: 3713304
    [No Abstract]   [Full Text] [Related]  

  • 2. [Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
    Gutiérrez Rodero F; Moya Jeromini I; Ortiz de la Tabla Ducasse V; Pozuelo González A
    Med Clin (Barc); 1985 May; 84(20):840. PubMed ID: 4033266
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME; Laguna F; González Lahoz J
    An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
    Morin D; Dumas ML; Valette H; Dumas R
    Arch Fr Pediatr; 1991 May; 48(5):349-51. PubMed ID: 1859238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 6. [Agranulocytosis in visceral leishmaniasis treated with glucantime].
    Bourée P; Dulac O
    Arch Fr Pediatr; 1977; 34(7):659-62. PubMed ID: 931516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxicity of Glucantime. A case].
    Katlama C; Régnier B; Ben Salah N; Pichard E; Vachon F
    Ann Med Interne (Paris); 1985; 136(4):321-2. PubMed ID: 4037587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of kala-azar in India.
    Thakur CP
    Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
    [No Abstract]   [Full Text] [Related]  

  • 9. Kala-azar in Afghanistan.
    Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
    J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
    Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
    Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 13. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 14. Side effects of treatment with antimony salts.
    Malta R; Affronti M; Di Rosa S; Vassallo L; Renda M; Trifirò G; Rubino ME; Rini GB
    J Chemother; 1989 Jul; 1(4 Suppl):628-9. PubMed ID: 16312564
    [No Abstract]   [Full Text] [Related]  

  • 15. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 17. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kala-azar in pregnant women].
    Massip P; Goutner C; Dupic Y; Navarrot P
    Presse Med; 1986 May; 15(20):933. PubMed ID: 2940581
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.